127-79-7 Usage
Chemical Properties
White Solid
Originator
Sulfamerazine,Lederle,US,1943
Uses
Antibacterial.
Definition
ChEBI: A sulfonamide consisting of pyrimidine with a methyl substituent at the 4-position and a 4-aminobenzenesulfonamido group at the 2-position.
Manufacturing Process
To a well agitated solution of 6.95 grams of 2-amino-6-methyl pyrimidine in
40 cc of pyridine, 15 grams of p-acetylaminobenzenesulfonyl chloride are
added in small portions over a 30 minute period. The reaction mixture is then
heated on a steam bath for 30 minutes, the free pyridine being then removed
under reduced pressure and the residue mixed with cold water, and the latter
mixture is vigorously stirred. The solid reaction product is removed by
filtration and washed with cold water.There is obtained a yield of 14 grams of crude 2-(pacetylaminobenzenesulfonamido)-
6-methyl pyrimidine, which on
recrystallization from alcohol and water melts at 238° to 239°C. The crude
product is hydrolyzed by suspending it in 400 cc of 2 N hydrochloric acid and
warming until solution is complete. The solution is neutralized with sodium
carbonate and the precipitated 2-(sulfanilamido)-6-methyl pyrimidine is
removed by filtration. The latter on recrystallization from alcohol and water
shows a melting point of 225° to 226°C.
Therapeutic Function
Antibacterial
Antimicrobial activity
Like all examined sulfanilamides, this drug is effective in treating infections caused by
streptococci, gonococci, pneumococci, staphylococci, and also colon bacillus. Synonyms
of this drug are dosulfin, polagin, romezin, and others.
General Description
Chemical structure: sulfonamide
Pharmaceutical Applications
2-Sulfonamido-4-methylpyrimidine. A component of some
triple sulfa combinations. Plasma half-life is c. 24 h and protein
binding c. 75%. It is less active than sulfadiazine.
Safety Profile
Moderately toxic by intravenous and subcutaneous routes. Experimental reproductive effects. When heated to decomposition it emits very toxic fumes of NO, and SOx,.
Synthesis
Sulfamerazine, N1
-(4-methyl-2-pyrimidinyl)sulfanilamide (33.1.12), is
also synthesized in the manner described above, which is by reacting 4-acetylaminobenzenesulfonyl chloride with 2-amino-4-methylpyrimidine (33.1.10), which is in turn synthesized by the traditional scheme of synthesizing derivatives of pyrimidine. Acetoacetic
ester is condensed with guanidine to give 4-methyl-2-aminopyrimidin-6-one (33.1.8).
Reacting this with phosphorous oxychloride gives 4-methyl-2-amino-6-chloropyrimidine
(33.1.9). The chlorine atom at C6 of the pyrimidine ring is then removed by reduction with
hydrogen using a palladium on carbon catalyst. The resulting 4-methyl-2-aminopyrimidine (33.1.10) is then reacted with 4-acetylaminobenzenesulfonyl chloride to make an
acetanilide derivative (33.1.11), the subsequent hydrolysis of which with base leads to the
formation of the desired sulfamerazine.
Check Digit Verification of cas no
The CAS Registry Mumber 127-79-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 7 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 127-79:
(5*1)+(4*2)+(3*7)+(2*7)+(1*9)=57
57 % 10 = 7
So 127-79-7 is a valid CAS Registry Number.
InChI:InChI=1/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)
127-79-7Relevant articles and documents
Structure-based virtual screening and optimization of modulators targeting Hsp90-Cdc37 interaction
Wang, Lei,Li, Li,Zhou, Zi-Han,Jiang, Zheng-Yu,You, Qi-Dong,Xu, Xiao-Li
, p. 63 - 73 (2017/05/10)
Identification of novel Hsp90 inhibitors to disrupt Hsp90-Cdc37 protein-protein interaction (PPI) could be an alternative strategy to achieve Hsp90 inhibition. In this paper, a series of small molecules targeting Hsp90-Cdc37 complex are addressed and characterized. The molecules' key characters are determined by utilizing a structure-based virtual screening workflow, derivatives synthesis, and biological evaluation. Structural optimization and structure–activity relationship (SAR) analysis were then carried out on the virtual hit of VS-8 with potent activity, which resulted in the discovery of compound 10 as a more potent regulator of Hsp90-Cdc37 interaction with a promising inhibitory effect (IC50?=?27?μM), a moderate binding capacity (KD?=?40?μM) and a preferable antiproliferative activity against several cancer lines including MCF-7, SKBR3 and A549?cell lines (IC50?=?26?μM, 15?μM and 38?μM respectively). All the data suggest that compound 10 exhibits moderate inhibitory effect on Hsp90-Cdc37 and could be regard as a first evidence of a non-natural compound targeting Hsp90-Cdc37 PPI.
